Patent Assignment
Reel/Frame 061879/0735
Change of Address
Recorded: 2022-11-03
Pages: 3
Assignor
ULTRAHUMAN FOUR LIMITED
Executed: 2021-11-30
Assignee
ULTRAHUMAN FOUR LIMITED
3RD FLOOR 1 ASHLEY ROAD, ALTRINCHAM, WA14 2DT, UNITED KINGDOM
Covered Property
(1)
Treating Cancer Using Nucleic Acid Encoding an Anti-CD47 Binding Agent
Application:
17/849,101 →
Publication:
US 2022/0332819
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 3, 2022
From: FINALY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 061648/0733 →
Corrective Assignment to Correct the Assignor's Name Previously Recorded at Reel: 061648 Frame: 0733. Assignor(S) Hereby Confirms the Assignment .
Dec 14, 2022
From: FINLAY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 062119/0110 →
Assignment of Assignor's Interest
Sep 28, 2023
From: ULTRAHUMAN FOUR LIMITED
To: CENTESSA PHARMACEUTICALS (UK) LIMITED
Reel/Frame 065058/0096 →
Security Interest
Dec 31, 2024
From: CENTESSA PHARMACEUTICALS (UK) LIMITED
To: OXFORD FINANCE LLC
Reel/Frame 069708/0039 →
Release of Security Interest
Jun 24, 2026
From: OXFORD FINANCE LLC
To: CENTESSA PHARMACEUTICALS (UK) LIMITED
Reel/Frame 075069/0879 →